<DOC>
	<DOCNO>NCT03102697</DOCNO>
	<brief_summary>This cohort study objective describe 12-month follow-up , weight loss obese patient submit treatment use two consecutively air-filled IGB ( Heliosphere® 600 cc Heliosphere 720 cc ) without interval removal first placement second .</brief_summary>
	<brief_title>Optimization Follow-up Consecutive Use Two Intragastric Balloons Treatment Obesity</brief_title>
	<detailed_description>Intragastric balloon ( IGB ) implantation widely use technique treat overweight subject mild obesity . The effectiveness air fill balloon ( Heliosphere BAG® ) improve weight loss , reduction BMI , percentage body weight loss , percentage excess weight loss complication six month placement notable . Several method available IGB placement new technique develop reduce discomfort procedure . Thus , use IGB effective method avoid bariatric surgery propose . However , precise protocol balance complication discomfort maximize weight loss still establish . Our secondary objective : - Describe weight loss , change BMI excess weight loss implantation first IGB removal ; - Describe change component metabolic syndrome ; - Describe change blood pressure ; - Estimate rate early explant ; - Describe condition surgery ; - Describe operative complication ; - To describe safety perioperative period , immediate postoperative period late postoperative period</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Class I obesity ( 3034.9 kg/m2 ) , Class II obesity ( 3539.5 kg/m2 ) overweight ( 2529.9 kg/m2 ) . Morbid obesity ( BMI &gt; 40kg/m2 ) , operative contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Intragastric balloon</keyword>
	<keyword>obesity</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>bariatric surgery</keyword>
</DOC>